# Clinical Proof-of-concept Study on Rapid Immune Modulating Effects

> **NCT05364710** · NA · UNKNOWN · sponsor: **Natural Immune Systems Inc** · enrollment: 24 (estimated)

## Conditions studied

- Immune Surveillance

## Interventions

- **DIETARY_SUPPLEMENT:** Transfer factor from colostrum ultrafiltrate

## Key facts

- **NCT ID:** NCT05364710
- **Lead sponsor:** Natural Immune Systems Inc
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-07
- **Primary completion:** 2022-12
- **Final completion:** 2023-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2022-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05364710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05364710, "Clinical Proof-of-concept Study on Rapid Immune Modulating Effects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05364710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*